Related Experiment Video
Updated: Jan 19, 2026
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides.
May T Aung-Htut1,2, Iain Comerford3, Russell Johnsen1,2
1Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, Western Australia, Australia.
Antisense oligonucleotides were developed to reduce integrin alpha 4 protein levels by targeting ITGA4 pre-mRNA. These splice-modulating compounds showed promise in a multiple sclerosis model, suggesting broader therapeutic potential.
Area of Science:
- Molecular Biology
- Pharmacology
- Neuroscience
Background:
- Antisense oligonucleotides (ASOs) are gaining traction as therapeutics for various diseases.
- Targeting pre-mRNA processing offers a novel therapeutic strategy for diseases linked to aberrant protein expression.
Purpose of the Study:
- To develop splice-modulating antisense oligonucleotides targeting the ITGA4 transcript.
- To investigate the potential of these ASOs in reducing integrin alpha 4 protein levels and ameliorating disease progression.
Main Methods:
- Designed over 100 antisense oligonucleotides to induce exon skipping in the ITGA4 transcript.
- Evaluated integrin alpha 4-mediated activities in human dermal fibroblasts and Jurkat cells.
- Assessed peptide-conjugated phosphorodiamidate morpholino ASOs in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Main Results:
- Successfully designed ASOs that induce exon skipping of the ITGA4 transcript, leading to reduced protein expression.
- Demonstrated efficacy in ameliorating disease progression in a mouse model of multiple sclerosis.
Conclusions:
- Splice-modulating antisense oligonucleotides targeting ITGA4 represent a promising therapeutic strategy for integrin alpha 4-mediated inflammatory diseases.
- This exon-skipping approach is adaptable for targeting other genes involved in splicing-dependent diseases.
Related Concept Videos
07:02Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:47Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
11:33Microinjection of mRNA and Morpholino Antisense Oligonucleotides in Zebrafish Embryos.
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
01:15Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
10:30Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy